Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akari Therapeutics Plc | Director | Ordinary Shares, par value $0.0001 per share | 71.7M | $43K | $0.00 | Jan 3, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKTX | Akari Therapeutics Plc | Jan 3, 2025 | 1 | $1.03K | 4 | Jan 7, 2025 | Director |
AKTX | Akari Therapeutics Plc | Dec 27, 2024 | 1 | $20K | 4 | Dec 30, 2024 | Director |
AKTX | Akari Therapeutics Plc | Dec 26, 2024 | 1 | $15K | 4 | Dec 27, 2024 | Director |
AKTX | Akari Therapeutics Plc | Dec 16, 2024 | 0 | $0 | 3 | Dec 26, 2024 | Director |